In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on G1 Therapeutics (GTHX – Research Report), with a price target of $71.00. The company’s shares closed last Thursday at $7.60, close to its 52-week low of $7.28.
According to TipRanks.com, White ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -17.6% and a 26.2% success rate. White covers the Healthcare sector, focusing on stocks such as Spectrum Pharmaceuticals, Karyopharm Therapeutics, and Silverback Therapeutics.
G1 Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $46.50, implying a 493.9% upside from current levels. In a report released yesterday, BTIG also assigned a Buy rating to the stock with a $51.00 price target.
G1 Therapeutics’ market cap is currently $324.6M and has a P/E ratio of -2.15.
Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GTHX in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
Read More on GTHX:
- H.C. Wainwright Believes Vertex Pharmaceuticals (VRTX) Still Has Room to Grow
- H.C. Wainwright Maintains a Hold Rating on Metacrine (MTCR)
- What Made H.C. Wainwright Downgrade Silverback Therapeutics’ Stock?
- H.C. Wainwright Maintains a Buy Rating on Corcept Therapeutics (CORT)
- H.C. Wainwright Keeps Their Buy Rating on ATAI Life Sciences (ATAI)